Indications
Invirase is indicated for the treatment of HIV-1-infected adult patients. Invirase should only be given in combination with ritonavir and other antiretroviral medicinal products.
Composition
- Active substance
- saquinavir
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Invirase
- Active substance
- saquinavir
- ATC code
- J05AE01
- Therapeutic area
- HIV Infections
- Marketing authorisation holder
- Roche Registration GmbH
- Status
- Withdrawn
- EU authorisation
- 3 Oct 1996